Table 2 Clinical and sociodemographic characteristics at treatment initiation for participants retained within the cohort and participants lost to follow-up (n = 9997)
From: Life expectancy of HIV-positive individuals on combination antiretroviral therapy in Canada
Characteristic | Total (n) | Not lost to follow-up (%) | Lost to follow-up (%) | P-value |
|---|---|---|---|---|
All Participants | 9997 | 8865 (88.7) | 1132 (11.3) | Â |
Sex | Â | Â | Â | 0.044 |
Female | 1831 | 1599 (87.3) | 232 (12.7) | Â |
Male | 8166 | 7266 (89.0) | 900 (11.0) | Â |
History of IDUa | Â | Â | Â | <0.001 |
Yes | 2141 | 1964 (91.7) | 177 (8.3) | Â |
No | 5702 | 5051 (88.6) | 651 (11.4) | Â |
Aboriginal ancestryb | Â | Â | Â | 0.001 |
Yes | 467 | 437 (93.6) | 30 (6.4) | Â |
No | 4275 | 3788 (88.6) | 487 (11.4) | Â |
CD4 cell count (cells/μL) |  |  |  | 0.002 |
<350 | 7689 | 6777 (88.1) | 912 (11.9) | Â |
≥350 | 2308 | 2088 (90.5) | 220 (9.5) |  |